Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Bayer Strengthens R&D
by Patricia L. Short
December 22, 2008
| A version of this story appeared in
Volume 86, Issue 51
Bayer has pledged to further expand its R&D activities despite the current economic crisis. "It is especially important at this time not just to patch things up for the short term but to expand one's vision and keep in mind the need for sustained success," Chairman Werner Wenning said during a recent press conference. He pointed out that the company's 2008 R&D investment of roughly $3.8 billion "represents the biggest R&D budget in Germany in the chemical and pharmaceutical sector and amounts to about 5% of all R&D spending by German industry as a whole."
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter